Expert Review of Clinical Immunology logo Expert Reviews logo

Expert Review of Clinical Immunology provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in disease states with a strong immunologic component, such as allergic asthma, rheumatoid arthritis, inflammatory bowel disease, psoriasis and multiple sclerosis

Publisher: Expert Reviews

More about this publication?
Related content
Volume 8, Number 2, February 2012

< previous issue | all issues | next issue >

Commentary

Etiology of autoimmune disease: past, present and future
pp. 111-113(3)
Authors: Alzabin, Saba; Venables, Patrick J

Autoimmune pancreatitis management: reflections on the past decade and the decade to come
pp. 115-117(3)
Authors: Pezzilli, Raffaele; Imbrogno, Andrea; Fabbri, Dario

News in brief

News in brief
pp. 119-121(3)

Drug Profile

Solanezumab for the treatment of mild-to-moderate Alzheimer''s disease
pp. 135-149(15)
Authors: Imbimbo, Bruno P; Ottonello, Simone; Frisardi, Vincenza; Solfrizzi, Vincenzo; Greco, Antonio; Seripa, Davide; Pilotto, Alberto; Panza, Francesco

Key Paper Evaluation

Contribution of celiac disease autoantibodies to the disease process
pp. 151-154(4)
Authors: Lindfors, Katri; Kaukinen, Katri

Special Report

Autoimmunity in X-linked agammaglobulinemia: Kawasaki disease and review of the literature
pp. 155-159(5)
Authors: Behniafard, Nasrin; Aghamohammadi, Asghar; Abolhassani, Hassan; Pourjabbar, Sarvenaz; Sabouni, Farah; Rezaei, Nima

Review

Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease
pp. 161-168(8)
Authors: Raza, Ali; Yousaf, Wajeeha; Giannella, Ralph; Shata, Mohamed Tarek

Safety of L-proline as a stabilizer for immunoglobulin products
pp. 169-178(10)
Authors: Hagan, John B; Wasserman, Richard L; Baggish, Jeffrey S; Spycher, Martin O; Berger, Melvin; Shashi, Vandana; Lohrmann, Emanuel; Sullivan, Kathleen E

Safety of L-proline as a stabilizer for immunoglobulin products
pp. 169-178(10)
Authors: Hagan, John B; Wasserman, Richard L; Baggish, Jeffrey S; Spycher, Martin O; Berger, Melvin; Shashi, Vandana; Lohrmann, Emanuel; Sullivan, Kathleen E

Filaggrin mutations and atopy: consequences for future therapeutics
pp. 189-197(9)
Authors: Heimall, Jennifer; Spergel, Jonathan M

Acknowledgements

Acknowledgements
pp. 199-199(1)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page